A recent study found that Cav-1 plays a crucial role in the PI3K/Akt-dependent upregulation of plasminogen activator inhibitor-1 (PAI-1), which promotes glioma proliferation and metastasis through an enhanced epithelial–mesenchymal transition (EMT) and angiogenesis. The gene discussed is CAV1; the disease is central nervous system cancer.